1
|
Lafranchi SH, Snyder DB, Sesser DE, et al:
Follow-up of newborns with elevated screening T4 concentrations. J
Pediatr. 143:296–301. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Olateju TO and Vanderpump MP: Thyroid
hormone resistance. Ann Clin Biochem. 43:431–440. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zavacki AM and Larsen PR: RTHalpha, a
newly recognized phenotype of the resistance to thyroid hormone
(RTH) syndrome in patients with THRA gene mutations. J Clin
Endocrinol Metab. 98:2684–2686. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Schoenmakers N, Moran C, Peeters RP,
Visser T, Gurnell M and Chatterjee K: Resistance to thyroid hormone
mediated by defective thyroid hormone receptor alpha. Biochim
Biophys Acta. 1830:4004–4008. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pohlenz J, Weiss RE, Macchia PE, et al:
Five new families with resistance to thyroid hormone not caused by
mutations in the thyroid hormone receptor beta gene. J Clin
Endocrinol Metab. 84:3919–3928. 1999.PubMed/NCBI
|
6
|
Fozzatti L, Lu C, Kim DW, et al:
Resistance to thyroid hormone is modulated in vivo by the nuclear
receptor corepressor (NCOR1). Proc Natl Acad Sci USA.
108:17462–17467. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bottcher Y, Paufler T, Stehr T, Bertschat
FL, Paschke R and Koch CA: Thyroid hormone resistance without
mutations in thyroid hormone receptor beta. Med Sci Monit.
13:CS67–CS70. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Işık E, Beck Peccoz P, Campi I, et al:
Thyroid hormone resistance: a novel mutation in thyroid hormone
receptor beta (THRB) gene- case report. Turk J Pediatr. 55:322–327.
2013.
|
9
|
Walsh S, Lowery AJ, Evoy D, McDermott EW
and Prichard RS: Thyroid lymphoma: recent advances in diagnosis and
optimal management strategies. Oncologist. 18:994–1003. 2013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Unluturk U, Sriphrapradang C, Erdogan MF,
et al: Management of differentiated thyroid cancer in the presence
of resistance to thyroid hormone and TSH-secreting adenomas: a
report of four cases and review of the literature. J Clin
Endocrinol Metab. 98:2210–2217. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ramos-Prol A, Antonia Perez-Lazaro M,
Isabel del Olmo-Garcia M, et al: Differentiated thyroid carcinoma
in a girl with resistance to thyroid hormone management with
triiodothyroacetic acid. J Pediatr Endocrinol Metab. 26:133–136.
2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Paragliola RM, Lovicu RM, Locantore P, et
al: Differentiated thyroid cancer in two patients with resistance
to thyroid hormone. Thyroid. 21:793–797. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sugita M, Harada H and Yamamoto T:
Perioperative management of a patient with thyroid hormone
resistance who underwent total thyroidectomy for thyroid cancer. J
Anesth. 26:595–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kim HK, Kim D, Yoo EH, et al: A case of
resistance to thyroid hormone with thyroid cancer. J Korean Med
Sci. 25:1368–1371. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Agrawal NK, Goyal R, Rastogi A, Naik D and
Singh SK: Thyroid hormone resistance. Postgrad Med J. 84:473–477.
2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Takeda K, Sakurai A, DeGroot LJ and
Refetoff S: Recessive inheritance of thyroid hormone resistance
caused by complete deletion of the protein-coding region of the
thyroid hormone receptor-beta gene. J Clin Endocrinol Metab.
74:49–55. 1992.PubMed/NCBI
|
17
|
Naderi N and Yang DT: Lymphoplasmacytic
lymphoma and Waldenstrom macroglobulinemia. Arch Pathol Lab Med.
137:580–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lin P, Molina TJ, Cook JR and Swerdlow SH:
Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas
with plasmacytic differentiation. Am J Clin Pathol. 136:195–210.
2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao L, Zhu X, Won Park J, Fozzatti L,
Willingham M and Cheng SY: Role of TSH in the spontaneous
development of asymmetrical thyroid carcinoma in mice with a
targeted mutation in a single allele of the thyroid hormone-beta
receptor. Endocrinology. 153:5090–5100. 2012. View Article : Google Scholar : PubMed/NCBI
|